The growth of deadly plaque inside the walls of arteries may not happen as scientists believed, research from the University of Toronto and Massachusetts General Hospital has found.
The research also suggests a new potential target in the treatment of atherosclerosis, a leading cause of cardiovascular disease and death globally.
The research team found that macrophages, white blood cells that drive atherosclerosis, replicate inside plaques. Moreover, this growth is not reliant on cells outside the plaques called monocytes, as scientists had assumed.
“Until now, the thinking was that inflammatory macrophages arise mainly from the recruitment of their precursors — monocytes — from the bloodstream,” said Clint Robbins, lead author on the study and an Assistant Professor in U of T’s Departments of Laboratory Medicine and Pathobiology, and Immunology. “Our study shows that the accumulation of macrophages also depends on their proliferation locally within the developing plaque.”
The journal Nature Medicine published the study results today.
The impact of the research on clinical treatments could be large. Many pharmaceutical companies are pouring resources into potential therapies that can block the recruitment of white blood cells into plaques. But if macrophages self-sustain through local cell division, blocking recruitment may not be the best strategy.
“I think this work will force some major re-evaluations,” said Filip Swirski, the study’s principal investigator who is a scientist in the Center for Systems Biology at Massachusetts General Hospital and an Assistant Professor at Harvard Medical School. “People have been thinking of targeting monocyte influx to treat atherosclerosis, but they need to consider macrophage proliferation as an additional or alternative approach, especially in established disease.”
That approach might be better than targeting circulating monocytes, since interrupting disease-causing processes within plaques could spare other beneficial immune responses that monocytes control, said Swirski.
As well, it could help improve the current standard of care in treating atherosclerosis: statin therapy. Statins, in addition to lowering blood lipids that contribute to plaque, have anti-inflammatory properties. The researchers are now looking at whether statins might limit the spread of macrophages within plaques.
“Additional targeting of macrophage proliferation may further decrease inflammation in atherosclerosis and prove clinically advantageous,” said Robbins, who is also a scientist in the Toronto General Research Institute at University Health Network.
The researchers conducted their study in mice, and they caution that much more research is needed to see how the work will translate to humans. But encouragingly, they found evidence of macrophage growth in plaques from human carotid arteries.
The Latest on: Heart disease
- Covid-19 infects intestines, kidneys and other organs, studies findon May 13, 2020 at 7:12 pm
The new coronavirus can infect organs throughout the body, including lungs, throat, heart, liver, brain, kidneys and the intestines, researchers found.
- How the Lyme disease epidemic is spreading and why ticks are so hard to stopon May 13, 2020 at 5:31 pm
Scientists traced the cause to tick bites and named it Lyme disease, but why it had suddenly appeared there was a mystery. Similar symptoms had been documented on Long Island, New York, years before.
- Cuomo: 102 New York Children Have Inflammatory Disease Possibly Linked To Coronavirus, A ‘Parent’s Worst Nightmare’on May 13, 2020 at 3:09 pm
New York Governor Andrew Cuomo said in a Wednesday press conference that the state is investigating 102 cases of children with the inflammatory, Kawasaki disease-like condition possibly connected to ...
- Seattle Sees 1st Rare Disease in Children Linked to Viruson May 13, 2020 at 1:39 pm
Seattle has had its first confirmed case of a rare inflammatory disease in children that has been closely linked to COVID-19.
- A New COVID-19 Syndrome In Children Has Pediatricians On Alert, Says This Infectious Disease Experton May 13, 2020 at 11:17 am
Though infection amongst children has been low, pediatricians are now reporting a new COVID-19 coronavirus syndrome that doesn't spare the young.
- Sugary drinks up heart disease risk in women by 20%: Studyon May 13, 2020 at 6:34 am
Women who drink one or more sugary beverages a day are more than 20 per cent more likely to be diagnosed with cardiovascular disease, warn researchers.
- Revealed: two men in China were first to receive pioneering stem-cell treatment for heart-diseaseon May 13, 2020 at 6:07 am
The two men are reportedly doing well one year on, but there is no way to confirm that the unpublished treatment using ‘reprogrammed’ stem cells works.
- Drinking sugary drinks every day could increase a woman's risk of heart disease and strokeon May 13, 2020 at 2:06 am
New US research has found that consuming one or more sugary drinks per day could increase a woman's risk of cardiovascular disease. Carried out by researchers at the University of California San Diego ...
- Soda, sugary drinks increase heart disease risk in women by 20%, study findson May 13, 2020 at 2:04 am
Women who drink one or sugary beverages a day are more than 20 percent more likely to be diagnosed with heart disease, a study published Wednesday by the Journal of the American Heart Association ...
- Gap between urban, rural heart disease death rates doubleson May 12, 2020 at 11:51 am
More and more residents of rural areas in the United States are dying from heart disease, a contrast from improving heart health seen in urban areas of the country, an analysis published Tuesday finds ...
via Google News and Bing News